Published in IRB on April 23, 1999
Determining risk in pediatric research with no prospect of direct benefit: time for a national consensus on the interpretation of federal regulations. Am J Bioeth (2007) 6.79
"You don't know me, but …": access to patient data and subject recruitment in human subjects research. Am J Bioeth (2011) 3.54
Burden of disease from inadequate water, sanitation and hygiene in low- and middle-income settings: a retrospective analysis of data from 145 countries. Trop Med Int Health (2014) 2.27
Assessing the impact of drinking water and sanitation on diarrhoeal disease in low- and middle-income settings: systematic review and meta-regression. Trop Med Int Health (2014) 1.64
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. J Clin Oncol (2006) 1.62
Ideal vs. real: revisiting contraceptive guidelines. IRB (2011) 1.38
Patients beware: commercialized stem cell treatments on the web. Cell Stem Cell (2010) 1.32
The use of normal children as participants in research on therapy. IRB (1997) 0.83
Scientific merit review: the role of the IACUC. Ilar News (1997) 0.82
A protocol review guide to reduce IRB inconsistency. IRB (1988) 0.79
Research involving the homeless: arguments against payment-in-kind (PinK). IRB (2004) 0.79
IRB review of a Phase II randomized clinical trial involving incompetent patients suffering from severe closed head injury. IRB (1994) 0.79
Measuring physicians' productivity in a Veterans' Affairs Medical Center. Acad Med (2003) 0.79
Women in early phase trials: an IRB's deliberations. IRB (2003) 0.78
Verification of IACUC approval and the just-in-time PHS grant process. ILAR J (2007) 0.78
Research knowledge among the participants in the Treatment for Adolescents With Depression Study (TADS). J Am Acad Child Adolesc Psychiatry (2007) 0.78
Treatment of refractory thrombotic thrombocytopenic purpura using multimodality therapy including splenectomy and cyclosporine. Transfus Apher Sci (2009) 0.76
Money matters. Am J Bioeth (2007) 0.75
Protecting patient privacy redux: response to open peer commentaries on "'you don't know me, but …': access to patient data and subject recruitment in human subjects research". Am J Bioeth (2012) 0.75
Bill of rights for research subjects. IRB (1993) 0.75
Ethical considerations in informed consent for potential future use of human tissue samples. IRB (1997) 0.75
An update on the PEG-SOD study involving incompetent subjects: FDA permits an exception to informed consent requirements. IRB (1994) 0.75
Selective review of external adverse events: one IRB's response to the avalanche of IND safety reports. IRB (2000) 0.75
Should IACUCs review scientific merit of animal research projects? Lab Anim (NY) (2004) 0.75
Can children be enrolled in a placebo-controlled randomized clinical trial of synthetic growth hormone? IRB (1989) 0.75
Continuing review of research involving human subjects: approach to the problem and remaining areas of concern. IRB (1998) 0.75
No Girls Allowed: A Sponsor's Rejection of One IRB's Contraception Policy. IRB (2016) 0.75